Europe Psoriasis Market and Competitive Landscape - 2017 - Product Image

Europe Psoriasis Market and Competitive Landscape - 2017

  • ID: 4377605
  • Report
  • Region: Europe
  • Fore Pharma
1 of 3
The latest research, Europe Psoriasis Market and Competitive Landscape - 2017, provides comprehensive insights into Psoriasis pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Psoriasis market size and drug sales. This research also provides insights into Psoriasis epidemiology and late stage pipeline.

The report is classified into nine sections - Psoriasis overview with definitions, symptoms, etiology, diagnosis, treatment options; Psoriasis pipeline insights covering late stage clinical trials pipeline; Psoriasis prevalence trends by countries; Psoriasis market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes EU5 countries - Germany, France, Italy, Spain, UK, Europe.

Research Scope:
  • Psoriasis pipeline: Find out the drugs in clinical trials for Psoriasis by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Psoriasis epidemiology: Find out the prevalence of Psoriasis by countries - Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
  • Psoriasis products: Identify key products marketed and prescribed for Psoriasis by brand name, by molecule, by company, by branded / generic, by countries - Europe, Germany, France, Italy, Spain, UK, Japan
  • Psoriasis market size: Find out the market size for Psoriasis drugs by countries - Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
  • Psoriasis drug sales: Find out the sales of Psoriasis drugs by countries - Europe, Germany, France, Italy, Spain, UK
  • Psoriasis drugs sales forecast: Sales forecast for Psoriasis drugs to 2021 by countries - Europe, Germany, France, Italy, Spain, UK, Japan
  • Psoriasis market share analysis: Find out the market shares of Psoriasis drugs and outlook by countries - Europe, Germany, France, Italy, Spain, UK, Japan
Benefits of this Research: The research helps executives to
  • Evaluate commercial market opportunities for Psoriasis drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in Psoriasis market
  • Develop in-depth knowledge of competition and markets
  • Analyze sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track market trends and analyze key events in Psoriasis market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies


This report will take 1-2 business days to deliver.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Psoriasis: Disease Overview
1.1. Psoriasis Symptoms
1.2. Psoriasis Etiology
1.3. Psoriasis Diagnosis
1.4. Psoriasis Treatment Options

2. Psoriasis Pipeline Insights
2.1. Psoriasis Phase 3 Clinical Trials
2.2. Psoriasis Phase 2 Clinical Trials
2.3. Psoriasis Phase 1 Clinical Trials

3. Psoriasis Epidemiology Analysis

4. Germany Psoriasis Market Insights
4.1. Marketed Products for Psoriasis in Germany
4.2. Germany Psoriasis Market Size & Forecast
4.3. Germany Psoriasis Product Sales Forecast
4.4. Germany Psoriasis Market Share Analysis

5. France Psoriasis Market Insights
5.1. Marketed Products for Psoriasis in France
5.2. France Psoriasis Market Size & Forecast
5.3. France Psoriasis Product Sales Forecast
5.4. France Psoriasis Market Share Analysis

6. Italy Psoriasis Market Insights
6.1. Marketed Products for Psoriasis in Italy
6.2. Italy Psoriasis Market Size & Forecast
6.3. Italy Psoriasis Product Sales Forecast
6.4. Italy Psoriasis Market Share Analysis

7. Spain Psoriasis Market Insights
7.1. Marketed Products for Psoriasis in Spain
7.2. Spain Psoriasis Market Size & Forecast
7.3. Spain Psoriasis Product Sales Forecast
7.4. Spain Psoriasis Market Share Analysis

8. UK Psoriasis Market Insights
8.1. Marketed Products for Psoriasis in UK
8.2. UK Psoriasis Market Size & Forecast
8.3. UK Psoriasis Product Sales Forecast
8.4. UK Psoriasis Market Share Analysis

9. Europe Psoriasis Market Insights
9.1. Europe Psoriasis Market Size & Forecast
9.2. Europe Psoriasis Product Sales Forecast
9.3. Europe Psoriasis Market Share Analysis

10. Research Methodology

List of Tables:
Table 1: Psoriasis Phase 3 Clinical Trials, Global, 2017
Table 2: Psoriasis Phase 2 Clinical Trials, Global, 2017
Table 3: Psoriasis Phase 1 Clinical Trials, Global, 2017
Table 4: Psoriasis Prevalence by EU5 Countries, 2012 - 2021
Table 5: Marketed Products for Psoriasis in Germany, 2017
Table 6: Germany Psoriasis Market Size & Forecast ($mn), 2012 - 2021
Table 7: Germany Psoriasis Product Sales ($mn), 2012 - 2021
Table 8: Germany Psoriasis Market Trends, 2012 - 2021
Table 9: Marketed Products for Psoriasis in France, 2017
Table 10: France Psoriasis Market Size & Forecast ($mn), 2012 - 2021
Table 11: France Psoriasis Product Sales ($mn), 2012 - 2021
Table 12: France Psoriasis Market Trends, 2012 - 2021
Table 13: Marketed Products for Psoriasis in Italy, 2017
Table 14: Italy Psoriasis Market Size & Forecast ($mn), 2012 - 2021
Table 15: Italy Psoriasis Product Sales ($mn), 2012 - 2021
Table 16: Italy Psoriasis Market Trends, 2012 - 2021
Table 17: Marketed Products for Psoriasis in Spain, 2017
Table 18: Spain Psoriasis Market Size & Forecast ($mn), 2012 - 2021
Table 19: Spain Psoriasis Product Sales ($mn), 2012 - 2021
Table 20: Spain Psoriasis Market Trends, 2012 - 2021
Table 21: Marketed Products for Psoriasis in UK, 2017
Table 22: UK Psoriasis Market Size & Forecast ($mn), 2012 - 2021
Table 23: UK Psoriasis Product Sales ($mn), 2012 - 2021
Table 24: UK Psoriasis Market Trends, 2012 - 2021
Table 25: Europe Psoriasis Market Size & Forecast ($mn), 2012 - 2021
Table 26: Europe Psoriasis Product Sales ($mn), 2012 - 2021

List of Figures:
Figure 1: Psoriasis Pipeline by Phase (%), Global, 2017
Figure 2: Psoriasis Prevalence by EU5 Countries, 2012 - 2021
Figure 3: Germany Psoriasis Market Size ($mn), 2012 - 2021
Figure 4: Germany Psoriasis Product Sales ($mn), 2012 - 2021
Figure 5: Germany Psoriasis Market Share by Products (%), 2016
Figure 6: Germany Psoriasis Market - Future Market Share (%), 2021
Figure 7: France Psoriasis Market Size ($mn), 2012 - 2021
Figure 8: France Psoriasis Product Sales ($mn), 2012 - 2021
Figure 9: France Psoriasis Market Share by Products (%), 2016
Figure 10: France Psoriasis Market - Future Market Share (%), 2021
Figure 11: Italy Psoriasis Market Size ($mn), 2012 - 2021
Figure 12: Italy Psoriasis Product Sales ($mn), 2012 - 2021
Figure 13: Italy Psoriasis Market Share by Products (%), 2016
Figure 14: Italy Psoriasis Market - Future Market Share (%), 2021
Figure 15: Spain Psoriasis Market Size ($mn), 2012 - 2021
Figure 16: Spain Psoriasis Product Sales ($mn), 2012 - 2021
Figure 17: Spain Psoriasis Market Share by Products (%), 2016
Figure 18: Spain Psoriasis Market - Future Market Share (%), 2021
Figure 19: UK Psoriasis Market Size ($mn), 2012 - 2021
Figure 20: UK Psoriasis Product Sales ($mn), 2012 - 2021
Figure 21: UK Psoriasis Market Share by Products (%), 2016
Figure 22: UK Psoriasis Market - Future Market Share (%), 2021
Figure 23: Europe Psoriasis Market Size ($mn), 2012 - 2021
Figure 24: Europe Psoriasis Product Sales ($mn), 2012 - 2021
Figure 25: Europe Psoriasis Market Share by Products (%), 2016
Figure 26: Europe Psoriasis Market - Future Market Share (%), 2021
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll